Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by GrahamBon Dec 04, 2024 5:54pm
121 Views
Post# 36346113

Capital Requirements

Capital Requirements

"Since Q2 we have pursued several financing initiatives to support our growth and commercialization efforts. These initiatives are designed to leverage commitments from our team and insiders while avoiding unnecessary dilution. Despite these efforts and carefully managing expenses it is essential that the company secures sufficient capital to execute our plans. To that end we have engaged investment bankers to assist with securing capital, plus marketing groups to increase awareness of the company and investment opportunity. We have shared in the past that current capital markets are the most challenging that anyone can remember in recent history. There is a sense that this will change but Ventripoint has near term capital requirements which must be addressed to achieve its milestones and exploit its window of opportunity." 

I saw the news release quoted above mentioned several times that conferences and growth initiatives have been significantly reduced due to the issue of capital. That's smart given they only had very limited cash a few months ago, negative working capital in the millions, and for some reason they can't close the finqncing as we approach a year.
Hopefully the bankers will help and retail will buy into the LIFE financing
Will likely be some discussion of this critical issue on the teleconference

allimo
fwiw
dyodd
and of course, for fun
dont own this long or short now

 

<< Previous
Bullboard Posts
Next >>